<header id=016982>
Published Date: 2013-11-30 12:27:41 EST
Subject: PRO/AH/EDR> Tularemia - USA (08): 2001-2010
Archive Number: 20131130.2083934
</header>
<body id=016982>
TULAREMIA - USA (08): 2001-2010
*******************************
A ProMED-mail post
http://www.promedmail.org
ProMED-mail is a program of the
International Society for Infectious Diseases
http://www.isid.org

Date: Thu 29 Nov 2013
Source: CDC. Morb Mortal Wkly Rep 62(47):963-966 [edited]
http://www.cdc.gov/mmwr/preview/mmwrhtml/mm6247a5.htm?s_cid=mm6247a5_w


Tularemia is a rare but potentially serious bacterial zoonosis that has been reported from all states in the USA except Hawaii. The etiologic agent, _Francisella tularensis_, is highly infectious and can be transmitted through arthropod bites, direct contact with infected animal tissue, inhalation of contaminated aerosols, and ingestion of contaminated food or water (1). _F. tularensis_ has been designated a Tier 1 select agent because it meets several criteria, including low infectious dose, ability to infect via aerosol, and a history of being developed as a bioweapon (2). This report summarizes tularemia cases reported to CDC during 2001-2010 via the National Notifiable Diseases Surveillance System (NNDSS) and compares the epidemiology of these cases with those reported during the preceding decade. During 2001-2010, a total of 1208 cases were reported (median: 126.5 cases per year; range: 90-154). Incidence was highest among children aged 5-9 years and men aged greater than 55 years. Clinicians and public health practitioners should be familiar with the current epidemiology and clinical features of tularemia to identify and adequately treat individual cases and recognize unusual patterns that might signal an outbreak or bioterrorism event.

In humans, _F. tularensis_ causes distinct clinical syndromes depending on the route of exposure. Percutaneous inoculation typically produces ulceroglandular tularemia, characterized by a cutaneous ulcer at the site of inoculation and tender regional lymphadenopathy. A less common presentation after percutaneous inoculation is glandular tularemia, in which patients develop regional lymphadenopathy without ulcer. Inhalation of _F. tularensis_ can result in a primary pneumonia, whereas ingestion causes oropharyngeal disease consisting of tonsillitis or pharyngitis with cervical lymphadenopathy. Other forms of tularemia include oculoglandular (infection of the eye) and typhoidal (fever without localizing signs) (3). Certain strains of _F. tularensis_ subspecies _tularensis_ (also known as type A) are associated with more severe disease and a greater risk for death (4,5). Mortality is less than 2 percent overall but ranges up to 24 percent depending on the strain (1,4).

For national surveillance purposes, a confirmed case of tularemia is defined as clinically compatible illness with either a 4-fold or greater change in serum antibody titer to _F. tularensis_ antigen or isolation of _F. tularensis_ from a clinical specimen. A probable case is defined as clinically compatible illness with either a single elevated antibody titer to _F. tularensis_ antigen or detection of _F. tularensis_ in a clinical specimen by fluorescent assay (6). In this report, incidence is calculated using 2005 census population estimates.

A total of 1208 cases of tularemia were reported via NNDSS during 2001-2010. The median number of cases per year was 126.5, with a range of 90-154 cases per year. Of these 1208 reported cases, 64 percent were categorized as confirmed and 35 percent as probable (Figure 1 [for figures and tables, see original URL - Mod.LL]). Median age of patients was 39 years (range: 1-92 years), and 68 percent were male. Average annual incidence was 0.041 cases per 100 000 persons. By age group and sex, annual incidence was highest among children aged 5-9 years (0.071) and among men aged 65-69 years (0.11) (Figure 2). Race was recorded for 887 patients (73 percent). Among these, 86 percent were white, 9 percent were American Indian/Alaska Native, and 3 percent were black. Ethnicity was recorded for 718 patients (59 percent), of whom 5 percent were Hispanic. The highest annual incidence by race was among American Indians/Alaska Natives (0.3 per 100 000 persons).

Cases were reported from 47 states (Figure 3). Of those, 6 states accounted for 59 percent of reported cases: Missouri (19 percent), Arkansas (13 percent), Oklahoma (9 percent), Massachusetts (7 percent), South Dakota (5 percent), and Kansas (5 percent). Among the 10 states with the highest incidence of tularemia, all but Massachusetts were located in the central or western United States (Table).

Tularemia cases were reported from 505 American counties (16 percent) during 2001-2010. County of residence was available for 1198 patients (99 percent), although in some cases this might not have been the county of exposure. Among these, 53 percent of patients resided in counties classified as rural by CDC National Center for Health Statistics' Urban-Rural Classification Scheme for Counties (7), although rural counties accounted for only 17 percent of the US population in 2006. The county with the highest annual incidence was Dukes County (Martha's Vineyard and the Elizabeth Islands), Massachusetts (67 cases; 43 per 100 000 persons). Cases in Dukes County were reported consistently during the 10-year period (range: 2-16 cases per year), with substantial increases in 2005 (11 cases), 2006 (10 cases), and 2008 (16 cases). Additional counties with high incidence rates were Buffalo County, South Dakota (6 cases; 29 per 100 000), and Shannon County, South Dakota (24 cases; 18 per 100 000).

The majority of cases (77 percent) occurred during May through September, consistent with peak arthropod activity and increased outdoor human activity. However, seasonal patterns varied by region. In the New England states, no cases occurred in the nonpeak winter months of December through March. In contrast, 20 percent of cases in the South Atlantic states, 15 percent in the East South Central states, and 14 percent in the Pacific states occurred from December through March.

The total number of cases reported during 2001-2010 was similar to the number reported during the 10-year period 1991-2000 (1208 versus 1216, respectively). Nevertheless, notable changes occurred in the number of cases reported from some individual states: Montana (72 percent decrease), Arkansas (42 percent decrease), South Dakota (29 percent decrease), Massachusetts (155 percent increase), Nebraska (120 percent increase), and Oklahoma (35 percent increase) (8).

Editorial Note:
During 2001-2010, the number and demographic features of reported tularemia cases were similar to those reported during the preceding decade. Nevertheless, several differences were noted between the 2 periods. The geographic distribution of reported cases was slightly less concentrated in the central states during 2001-2010, with a greater proportion of cases reported from the Northeast and the Pacific states of Washington and California than in previous years. In addition, 4 states that had not reported cases during 1991-2000 (Connecticut, New Hampshire, Vermont, and West Virginia) reported cases during 2001-2010. Further investigation is needed to determine whether the change in distribution was caused by alterations in reporting patterns, vector distribution, human behavior, or other factors.

Seasonal variations by region are likely attributable in part to climate differences, because states with milder climates have longer arthropod activity and thus extended periods of risk. Seasonal variations might also reflect, to some extent, hunting activities that can occur year-round, in contrast to landscaping and other outdoor recreational activities that are concentrated in the summer months. Hunting can result in human exposure to tularemia through direct contact with infected animals and ingestion of infected meat. Hunting of rabbits, which typically occurs in the fall and winter, might explain the higher proportion of winter cases in South Atlantic and East South Central states, where small game hunting is common (9).

In a previous surveillance report for the period 1990-2000, CDC recommended improving surveillance by increasing documentation of laboratory confirmation and collecting more detailed epidemiologic and clinical data (8). Documentation of laboratory confirmation has indeed improved; during 1990-2000, only 65 percent of case reports included documentation indicating whether they met the probable versus confirmed case definition, compared with 99 percent during 2001-2010. Although the amount of epidemiologic and clinical data collected through NNDSS has not changed, CDC does regularly request additional patient information from health departments to better characterize the disease.

The findings in this report are subject to at least 2 limitations: 1st, the tularemia cases described in this report might not be fully representative of all cases diagnosed in the United States because case ascertainment and reporting might be incomplete and differ by state; 2nd, missing data and small numbers limit statistical comparisons and interpretation.

Tularemia is not a common disease, but it continues to cause approximately 100 reported human cases annually in the United States and is a serious and potentially fatal disease. Although outbreaks do occur (10), the majority of reported tularemia cases in the United States are sporadic. Clinicians should consider tularemia in patients with a compatible clinical profile, particularly in children and elderly males with acute fever and regional lymphadenopathy. This report shows that the distribution of tularemia might be gradually changing; therefore, tularemia should be considered even in areas where it has rarely been reported.

State and local public health departments are encouraged to report tularemia cases in a timely manner and provide additional patient information, including exposure history, clinical syndrome, and outcome, to CDC when possible. Because the threat of bioterrorism remains, clinicians and health departments should remain vigilant; for example, an urban cluster of tularemia cases among persons without a common natural exposure could be the 1st sign of a bioterrorism attack.

References
------------
1. Dennis DT, Inglesby TV, Henderson DA, et al: Tularemia as a biological weapon: medical and public health management. JAMA 2001;285:2763-73.
2. US Department of Health and Human Services: Possession, use, and transfer of select agents and toxins; biennial review. Fed Regist 2012;77(194).
3. Eliasson H, Broman T, Forsman M, BÃ¤ck E: Tularemia: current epidemiology and disease management. Infect Dis Clin N Am 2006;20:289-311.
4. Kugeler KJ, Mead PS, Janusz AM, et al: Molecular epidemiology of _Francisella tularensis_ in the United States. Clin Infect Dis 2009;48:863-70.
5. Staples JE, Kubota KA, Chalcraft LG, Mead PS, Petersen JM: Epidemiologic and molecular analysis of human tularemia, United States, 1964-2004. Emerg Infect Dis 2006;12:1113-8.
6. CDC: Tularemia surveillance case definition. Atlanta, GA: US Department of Health and Human Services, CDC; 2013. Available at http://wwwn.cdc.gov/nndss/script/casedef.aspx?condyrid=880&datepub=1/1/1999%2012:00:00%20am.
7. Ingram DD, Franco SJ: NCHS urban-rural classification scheme for counties. Vital Health Stat 2012;2(154).
8. CDC: Tularemia -- United States, 1990-2000. MMWR 2002;51:182-4.
9. US Fish and Wildlife Service; US Census Bureau: 2006 national survey of fishing, hunting, and wildlife-associated recreation. Washington, DC: US Department of the Interior, US Fish and Wildlife Service; US Census Bureau, US Department of Commerce; 2008. Available at http://www.census.gov/prod/2008pubs/fhw06-nat.pdf.
10. Calanan R, Rolfs R, Summers J, et al: Tularemia outbreak associated with outdoor exposure along the western side of Utah Lake, Utah, 2007. Public Health Rep 2010;125:870-6.

[Authors: Nelson C, Kugeler K, Petersen J, Mead P]

--
Communicated by:
ProMED-mail
<promed@promedmail.org>

[Human infection with _Francisella tularensis_, a Category (or tier) A bioterrorism agent, continues to be a problem on Martha's Vineyard and Nantucket, islands off the southern coast of Cape Cod in Massachusetts, as reflected in this data. A substantial number of the cases are pneumonic, occurring in landscapers and gardeners, related to the aerosolization of infective bacteria.

Telford and colleagues (1) have investigated the genetic diversity of _F. tularensis_ obtained from Martha's Vineyard ticks. Between 2001 and 2003, 0.7 per cent of 4246 dog ticks (_Dermacentor variabilis_) harbored the tularemia bacillus, and there was a degree of genotypic diversity suggestive of long-standing enzootic transmission of the infection on the island. The authors review information regarding the island's tularemia, which appears to have been a relatively recent introduction into Massachusetts. They state that prior to 1937, only one case of the infection was recognized, related to contaminated rabbit meat from the Midwest USA. In 1937, however, more than 20 000 cottontail rabbits from the Midwest states of Missouri and Kansas were introduced into the Massachusetts mainland and Martha's Vineyard and Nantucket for sporting purposes (2). Cases began to occur starting several years later.

Another interesting observation relates to tularemia's role in the search for evidence of bioterrorism using air sensor detectors of the BioWatch program. At least 3 episodes of air screening positivity for tularemia occurred during this decade in Saint Louis, Missouri; Washington, DC; and Houston, Texas; no human cases occurred during those episodes and all 3 likely not related to any deliberate event. Additionally, cases of tularemia can be found in urban areas, even in New York City.

1. Goethert HK, Shani I, Telford SR. Genotypic diversity of _Francisella tularensis_ infected _Dermacentor variabilis_ ticks on Martha's Vineyard, Massachusetts. J Clin Microbiol 2004; 42: 4968-73.
2. Belding DL, Merrill M. Tularemia in imported rabbits in Massachusetts. N Engl J Med 1941; 1085-87.
- Mod.LL

A HealthMap/ProMED-mail map can be accessed at: http://healthmap.org/r/1hiS.]
See Also
Tularemia - USA (07): (MA) 20130905.1926007
Tularemia - USA (05): (AK) snowshoe hare 20130702.1802498
Tularemia - USA (04): (NE) 20130629.1798960
Tularemia - USA (03): (NM) human, feline, canine, alert 20130628.1797147
Tularemia - USA (02): (NE) 20130624.1789311
Tularemia - USA: (NC) hunters 20130226.1560910
2011
----
Tularemia - USA: (DE) 20111011.3043
Tularemia, feline - USA: (IL) 20110916.2823
Tularemia, pneumonic - Taiwan: (Taipei) ex USA 20110812.2445
Tularemia, wildlife - USA: (TX) feral hogs, alert 20110127.0327
2006
----
Tularemia, air sensor detection - USA (MO) 20061020.3018
2005
----
Tularemia, air sensor detection - USA (DC)(05) 20051012.2970
Tularemia, air sensor detection - USA (DC) 20051005.2900
2004
----
Tularemia, pneumonic - USA (NYC)(04) 20041115.3081
Tularemia, pneumonic - USA (NYC) 20041110.3033
2003
----
Tularemia, air sensor detection - USA (TX) 20031023.2657
1998
----
Tularemia - USA (New York City) (03) 19980804.1490
Tularemia - USA (New York City): RFI 19980724.1405
.................................................ll/je/jw
</body>
